Highly active antiretroviral therapy and beta-chemokines.

about

Highly active antiretroviral therapy and beta-chemokines.

Item

http://www.wikidata.org/entity/Q44991108

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Highly active antiretroviral therapy and beta-chemokines.

@en

Highly active antiretroviral therapy and beta-chemokines.

@nl

type

Item

label

Highly active antiretroviral therapy and beta-chemokines.

@en

Highly active antiretroviral therapy and beta-chemokines.

@nl

prefLabel

Highly active antiretroviral therapy and beta-chemokines.

@en

Highly active antiretroviral therapy and beta-chemokines.

@nl

P1476

Highly active antiretroviral therapy and beta-chemokines.

@en

P2093

B Brichacek

http://www.w3.org/2001/XMLSchema#string

M Bukrinsky

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

The biology of chemokines and their receptors

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

P304

169-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1046/J.1365-2249.2002.02010.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11072518

http://www.w3.org/2001/XMLSchema#string

P698

12390302

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

1906529

http://www.w3.org/2001/XMLSchema#string